Company Intelligence

958 companies tracked — sector, funding, valuation and headline metrics, sourced and dated.

Clear

Companies

74 matches
Attovia Therapeutics
Public
Biotech

Attovia Therapeutics is a clinical-stage biotech developing ATTOBODY-based biotherapeutics for immu…

~$588M ($256M private + $332M IPO gross…
Apnimed
Public
Biotech

Clinical-stage biotech developing Oxnimbi (AD109), the first investigational oral pill for obstruct…

Braveheart Bio
Biotech
Latigo Biotherapeutics
Biotech
Scribe Therapeutics
Public
Biotech

Clinical-stage biotech developing CRISPR-based gene-editing therapeutics using its proprietary CasX…

Celea Therapeutics
Biotech

Clinical-stage biotech developing deupirfenidone, a deuterated pirfenidone-derived drug for idiopat…

$180M total funding · Jul 31, 2026
Colossal Biosciences
Biotech

Colossal Biosciences is a genetic engineering company working to de-extinct species like the woolly…

$10.3B valuation · Jul 31, 2026
Ollin Biosciences
Biotech

Clinical-stage biopharmaceutical company developing best-in-disease therapies for vision-threatenin…

$430M total funding · Jul 30, 2026
AEON Biopharma
Public
Biotech

Clinical-stage biopharmaceutical company developing ABP-450 (prabotulinumtoxinA), a biosimilar to B…

Assort Health
Biotech

Assort Health builds AI voice agents that automate patient access workflows for healthcare organiza…

$1.2B valuation · Jul 30, 2026
Chai Discovery
Biotech

Chai Discovery builds generative AI foundation models that predict and design protein and antibody…

$3.8B valuation · Jul 31, 2026
Drug Farm
Biotech

Drug Farm is a biotech developing AI-designed small-molecule drugs for rare and immune-inflammatory…

$138M total funding · Jul 31, 2026
Encore Medical
Public
Biotech

Encore Medical develops transcatheter septal occlusion devices to repair structural heart defects l…

Flare Therapeutics
Biotech

Flare Therapeutics is a clinical-stage biotech developing small-molecule drugs that target transcri…

$290M total funding · Jul 31, 2026
Jupiter Neurosciences
Public
Biotech

Clinical-stage biotech developing JOTROL, a proprietary high-bioavailability resveratrol platform t…

OneMedNet
Public
Biotech

OneMedNet provides a platform for curating and exchanging real-world medical imaging and clinical d…

PureTech
Public
Biotech

PureTech Health is a publicly traded biopharmaceutical company that discovers, develops, and commer…

Sanofi
Public
Biotech

Sanofi is a global biopharmaceutical company developing and manufacturing medicines and vaccines ac…

Shionogi
Public
Biotech

Japanese pharmaceutical company developing prescription drugs, infectious disease therapies, and sp…

Tenon Medical
Public
Biotech

Tenon Medical develops the Catamaran, a minimally invasive titanium implant system for sacroiliac j…

Triveni Bio
Biotech

Triveni Bio develops genetics-informed antibody and bispecific therapeutics for immunological and i…

$272M total funding · Jul 31, 2026
Astromech
Biotech
AusperBio Therapeutics
Biotech
BillionToOne
Biotech
BlossomHill
Biotech
BlossomHill Therapeutics
Biotech
Dare Bioscience
Biotech
Serina Therapeutics
Biotech
Vogenx
Biotech
Adaptyv Bio
Biotech
AIM ImmunoTech
Biotech
Akari Therapeutics
Biotech
Alzamend Neuro
Biotech
Aptevo Therapeutics
Biotech
Aureka Biotechnologies
Biotech
Axiom AIOSciences
Biotech
Beeline Medicine
Biotech
Beeline Medicines
Biotech
bioAffinity Technologies
Biotech
Biote
Biotech
Breakthru Medicine
Biotech
Bridge to Life
Biotech
Bristol Myers Squibb
Biotech
Caris Life Sciences
Biotech
Crystalys Therapeutics
Biotech
Curium
Biotech
Cyllene Therapeutics
Biotech
Danimer Scientific
Biotech